Seminars in Radiation Oncology
Volume 12, Issue 3, Supplement , Pages 11-20, July 2002

Epidermal growth factor receptor as a therapeutic target in head and neck cancer☆☆

University of Alabama at Birmingham; and ImClone Systems Incorporated, New York, NY.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. No PDF version available.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Bonner is a paid consultant for ImClone Systems.

☆☆ Address reprint requests to James A. Bonner, MD, Department of Radiation Oncology, University of Alabama at Birmingham, 105 Wallace Tumor Institute, 1824 6th Ave South, Birmingham, AL 35294-3300.

PII: S1053-4296(02)70045-3

Seminars in Radiation Oncology
Volume 12, Issue 3, Supplement , Pages 11-20, July 2002